Theraclion S.A.
ALTHE.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | – | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | – | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 114.8% | -12.1% | -47.5% | – |
| Gross Profit | -€0 | -€0 | -€0 | -€0 |
| % Margin | -353.5% | -1,039.3% | -708.4% | -49.3% |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | -331.4% | -745.3% | -627.5% | -193.6% |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -304.3% | -873.9% | -534.6% | -142.5% |
| EPS Diluted | -0.055 | -0.073 | -0.052 | -0.026 |
| % Growth | 25.1% | -41.6% | -97.3% | – |
| Operating Cash Flow | -€0 | -€0 | -€0 | -€0 |
| Capital Expenditures | -€0 | -€0 | -€0 | €0 |
| Free Cash Flow | -€0 | -€0 | -€0 | €0 |